Skip to main
EHC

Encompass Health (EHC) Stock Forecast & Price Target

Encompass Health (EHC) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Encompass Health is well-positioned to capitalize on the growing demand for post-acute healthcare services, with a strong track record of financial performance and potential for expansion through its successful Medicare Advantage strategy. However, potential risks include changes to Medicare payment systems and potential rate cuts. The company's low debt and consistent cash flow generation provide a solid foundation for growth and shareholder returns.

Bears say

Encompass Health is facing several challenges, including slower growth, reduced reimbursement, and regulatory risks, which could have a negative impact on the company's financial performance. Additionally, the company's reliance on a single segment for majority of its revenue could make it vulnerable to changes in the healthcare industry. Long-term factors such as staffing challenges and stricter regulations could also affect the company's valuation and long-term prospects.

Encompass Health (EHC) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Encompass Health (EHC) Forecast

Analysts have given Encompass Health (EHC) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Encompass Health (EHC) has a Strong Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $148.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $148.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Encompass Health (EHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.